Related Experiment Video
Updated: May 16, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Crystal structures of HIV-1 reverse transcriptase with picomolar inhibitors reveal key interactions for drug design
Kathleen M Frey1, Mariela Bollini, Andrea C Mislak
1Department of Chemistry, Yale University, New Haven, Connecticut 06520-8107, United States.
Abstract:
X-ray crystal structures at 2.9 Å resolution are reported for two complexes of catechol diethers with HIV-1 reverse transcriptase. The results help elucidate the structural origins of the extreme antiviral activity of the compounds. The possibility of halogen bonding between the inhibitors and Pro95 is addressed. Structural analysis reveals key interactions with conserved residues P95 and W229 of importance for design of inhibitors with high potency and favorable resistance profiles.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Protein-protein Interfaces
Retrovirus Life Cycles

